Hubei Pharmaceutical Group Announces Acquisition of New Joint Venture Completed September 7th, 2004
07 sept. 2004 14h24 HE
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 7, 2004 (PRIMEZONE) -- Hubei Pharmaceutical Group (OTCBB:HBEI) (Frankfurt:HUQ) announced today that acquisition of it's new joint venture, a 60% controlling interest in Hubei Tongji...